Advertisement

Topics

Avid Radiopharmaceuticals, Inc. Company Profile

13:04 EDT 25th September 2017 | BioPortfolio

Avid Radiopharmaceuticals is a leader in the development of molecular imaging products with the potential for earlier and more effective detection, diagnosis and monitoring of major chronic human diseases. Based in Philadelphia, PA, the company’s lead program is a molecular imaging agent for amyloid plaque that could lead to earlier detection and better evaluation of drugs designed to prevent or reverse amyloid plaque build-up in the brain. Avid is currently conducting Phase III clinical studies of florbetapir for imaging amyloid plaques in Alzheimer's disease, and is in Phase I and II trials with 18F-AV-133 for imaging the vesicular monoamine transporter (VMAT2) in diseases involving dopaminergic degeneration (Parkinson's disease and Dementia with Lewy Bodies) and beta cell dysfunction (Type I and Type II Diabetes Mellitus). For more information, please visit www.avidrp.com.


News Articles [37 Associated News Articles listed on BioPortfolio]

Global Radiopharmaceuticals Market 20172021 [Report Updated: 09082017] Prices from USD $3500

About RadiopharmaceuticalsRadiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that...

Avid Bioservices’ Parent Cuts R&D and Mfg. Staff

Peregrine reduces overall workforce by 20%

Avid Bioservices to Exhibit at 2017 BioProcess International Conference & Exhibition

TUSTIN, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), today announced that the comp...

Peregrine Announces Appointment Of As President Of Avid Bioservices, Inc.

  Life Sciences Jobs   ...

Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D. as President of Avid Bioservices

TUSTIN, Calif., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturin...

Avid Bioservices Expands Manufacturing Capabilities With Installation and Validation of Two MilliporeSigma Mobius® 2,000-Liter Single-Use Bioreactors in Its Myford Facility

-- Bioreactors Now Online and Able to Meet Needs of Current and Future Clients -- -- State-of-the-Art Myford Facility Features Industry-Leading Flexibility, Scalability and Ease-of-Use -- TUSTIN...

Radiopharmaceuticals Market: Will Japan Expected to Register an Attractive Growth Rate Throughout the Forecast Period Beat Current Market Leader North America? Global Industry Analysis and Opportunity Assessment, 20162026 [Updated: 08022017] Prices from

North America is anticipated to be the most attractive regional market in the global radiopharmaceuticals marketNorth America accounted for more than 40% market share in the global radiopharmaceutical...

World Nuclear Medicine/Radiopharmaceuticals Market Opportunities and Forecasts, 2014 2022 [Report Updated: 07072016] Prices from USD $5370

Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substa...

PubMed Articles [102 Associated PubMed Articles listed on BioPortfolio]

(188)Re(V) Nitrido Radiopharmaceuticals for Radionuclide Therapy.

The favorable nuclear properties of rhenium-188 for therapeutic application are described, together with new methods for the preparation of high yield and stable (188)Re radiopharmaceuticals character...

68Ga-PSMA Uptake in Combined Hepatocellular Cholangiocarcinoma With Skeletal Metastases.

Ga-PSMA PET is a rapidly evolving imaging modality for whole-body staging of prostate cancer. We report a case of a 70-year-old man with mildly elevated prostate-specific antigen (8.1 μg/L) and clini...

99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy: A prospective observational study.

The aim of this study is to determine the contribution of neck and chest Tc-pertechnetate scan to the management of postoperative patients with suspicious metastatic differentiated thyroid cancer (DTC...

Technetium-99m Radiochemistry for Pharmaceutical Applications.

(99m) Tc is a widely used radionuclide and the development of (99m) Tc imaging agents continues to be in demand. This overview discusses basic principles of (99m) Tc radiopharmaceutical preparation an...

Blastic Plasmacytoid Dendritic Cell Neoplasm Evaluated by FDG PET/CT.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological malignancy. A 34-year-old man with a biopsy-proven BPDCN underwent FDG PET/CT for staging. FDG PET/CT reveal...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Antiarrhythmics Versus Implantable Defibrillators (AVID)

To evaluate if use of an implantable cardiac defibrillator (ICD) results in reduction in total mortality, when compared with conventional pharmacological therapy, in patients resuscitated...

Combination Targeted Radiotherapy in Neuroendocrine Tumors

RESEARCH PLAN / BACKGROUND AND SIGNIFICANCE: Tumors originating from the neuroendocrine system, although relatively rare, may be life threatening. In cases where the disease has metastasi...

18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.

18F ion is a positron emitting bone radiopharmaceuticals. The skeletal uptake of 18F relies on the exchange of hydroxyl ions in the hydroxyapatit crystal which is an indicator of bone meta...

PET-CT vs DWI-MRI in Response Evaluation in Esophageal Cancer

In patients with esophageal cancer (EC) neo-adjuvant chemoradiation (nCRT) followed by surgery with curative intent leads to objective responses in 45 to 60%, whereas 20-35% of the patient...

Companies [34 Associated Companies listed on BioPortfolio]

Avid Radiopharmaceuticals

Founded in 2004, Avid Radiopharmaceuticals, Inc. is a product-focused molecular imaging company that is a pioneer in developing radiopharmaceuticals for imaging Alzheimer's disease pathology. Two of A...

Avid Radiopharmaceuticals, Inc.

Avid Radiopharmaceuticals is a leader in the development of molecular imaging products with the potential for earlier and more effective detection, diagnosis and monitoring of maj...

Avid Bioservices, Inc.

Avid Bioservices provides a comprehensive range of cGMP manufacturing services for the biotechnology and biopharmaceutical industries. Avid manufactures cGMP commercial product, as well as clinical s...

Coquí RadioPharmaceuticals Corp.

Coquí RadioPharmaceuticals Corp. is a medical isotope company, dedicated to the production of Molybdenum-99, which is used in 20 million procedures each year in the U.S. The Pu...

CORAR

The Council on Radionuclides and Radiopharmaceuticals (CORAR) is an association comprised of companies in the United States and Canada who manufacture and distribute radiopharmace...

More Information about "Avid Radiopharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Avid Radiopharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Avid Radiopharmaceuticals, Inc. Clinical Trials and PubMed Articles about Avid Radiopharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avid Radiopharmaceuticals, Inc. Companies in our database. You can also find out about relevant Avid Radiopharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record